Brief Summary
Type:
Multiple Sites (Solid Tumors)
Study Type:
Treatment
Phase:
III
ClinicalTrials.gov Identifier:
NCT02900976
Study #:
CMH - ANHL1522
Start Date:
Jun 12, 2019
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT02900976
View Complete Trial Details & Eligibility at ClinicalTrials.gov
